Publication: Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro
dc.contributor.author | Dimas, K. | |
dc.contributor.author | Yerlikaya, Azmi | |
dc.contributor.buuauthor | Ulukaya, Engin | |
dc.contributor.buuauthor | Sarımahmut, Mehmet | |
dc.contributor.buuauthor | Cevatemre, Buse | |
dc.contributor.buuauthor | Arı, Ferda | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Fen Edebiyat Fakültesi | |
dc.contributor.department | Tıbbi Biyokimya Ana Bilim Dalı | |
dc.contributor.department | Biyoloji Bölümü | |
dc.contributor.orcid | 0000-0003-2647-5875 | |
dc.contributor.orcid | 0000-0002-6729-7908 | |
dc.contributor.orcid | 0000-0003-4875-5472 | |
dc.contributor.researcherid | K-5792-2018 | |
dc.contributor.researcherid | AAG-8288-2021 | |
dc.contributor.researcherid | AAG-7012-2021 | |
dc.contributor.researcherid | AHD-2050-2022 | |
dc.contributor.scopusid | 6602927353 | |
dc.contributor.scopusid | 44661687400 | |
dc.contributor.scopusid | 55693788600 | |
dc.contributor.scopusid | 24376085300 | |
dc.date.accessioned | 2024-03-05T07:58:58Z | |
dc.date.available | 2024-03-05T07:58:58Z | |
dc.date.issued | 2014-03-13 | |
dc.identifier.citation | Ulukaya, E. vd. (2014). "Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro". Biomedicine and Pharmacotherapy, 68(4), 477-482. | |
dc.identifier.doi | https://doi.org/10.1016/j.biopha.2014.03.013 | |
dc.identifier.eissn | 1950-6007 | |
dc.identifier.endpage | 482 | |
dc.identifier.issn | 0753-3322 | |
dc.identifier.issue | 4 | |
dc.identifier.pubmed | 24755119 | |
dc.identifier.scopus | 2-s2.0-84901590452 | |
dc.identifier.startpage | 477 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0753332214000419 | |
dc.identifier.uri | https://hdl.handle.net/11452/40199 | |
dc.identifier.volume | 68 | |
dc.identifier.wos | 000336538400012 | |
dc.indexed.wos | SCIE | |
dc.language.iso | en | |
dc.publisher | Elsevier | |
dc.relation.bap | UAP(T)-2010/37 | |
dc.relation.collaboration | Yurt içi | |
dc.relation.collaboration | Yurt dışı | |
dc.relation.journal | Biomedicine and Pharmacotherapy | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Breast cancer | |
dc.subject | Cytotoxicity | |
dc.subject | Chemotherapy | |
dc.subject | Fenretinide | |
dc.subject | TRAIL | |
dc.subject | Growth-inhibition | |
dc.subject | Death receptors | |
dc.subject | Cisplatin | |
dc.subject | Induction | |
dc.subject | Identification | |
dc.subject | Combination | |
dc.subject | P53 | |
dc.subject | Target | |
dc.subject | Mechanism | |
dc.subject | Trial | |
dc.subject | Research & experimental medicine | |
dc.subject | Pharmacology & pharmacy | |
dc.subject.emtree | Adenosine triphosphate | |
dc.subject.emtree | Caspase 3 | |
dc.subject.emtree | Fenretinide | |
dc.subject.emtree | Nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase | |
dc.subject.emtree | Tumor necrosis factor related apoptosis inducing ligand | |
dc.subject.emtree | Antineoplastic agent | |
dc.subject.emtree | Drug effects | |
dc.subject.emtree | Fenretinide | |
dc.subject.emtree | Apoptosis | |
dc.subject.emtree | Article | |
dc.subject.emtree | Breast cancer | |
dc.subject.emtree | Breast metastasis | |
dc.subject.emtree | Cancer cell culture | |
dc.subject.emtree | Cell death | |
dc.subject.emtree | Cell structure | |
dc.subject.emtree | Cell viability assay | |
dc.subject.emtree | Cytotoxicity | |
dc.subject.emtree | Enzyme linked immunosorbent assay | |
dc.subject.emtree | Fluorescence imaging | |
dc.subject.emtree | Fluorescence microscopy | |
dc.subject.emtree | In vitro study | |
dc.subject.emtree | Polyacrylamide gel electrophoresis | |
dc.subject.emtree | Priority journal | |
dc.subject.emtree | Western blotting | |
dc.subject.emtree | Apoptosis | |
dc.subject.emtree | Breast neoplasms | |
dc.subject.emtree | Drug potentiation | |
dc.subject.emtree | Female | |
dc.subject.emtree | Human | |
dc.subject.emtree | Metabolism | |
dc.subject.emtree | Metastasis | |
dc.subject.emtree | Pathology | |
dc.subject.emtree | Tumor cell line | |
dc.subject.mesh | Antineoplastic combined chemotherapy protocols | |
dc.subject.mesh | Apoptosis | |
dc.subject.mesh | Blotting, western | |
dc.subject.mesh | Breast neoplasms | |
dc.subject.mesh | Caspase 3 | |
dc.subject.mesh | Cell line, tumor | |
dc.subject.mesh | Drug synergism | |
dc.subject.mesh | Enzyme-linked immunosorbent assay | |
dc.subject.mesh | Female | |
dc.subject.mesh | Fenretinide | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Microscopy, fluorescence | |
dc.subject.mesh | Neoplasm metastasis | |
dc.subject.mesh | Poly(adp-ribose) polymerases | |
dc.subject.mesh | Tnf-related apoptosis-inducing ligand | |
dc.subject.scopus | Fenretinide; Apoptosis; Neuroblastoma | |
dc.subject.wos | Medicine, research & experimental | |
dc.subject.wos | Pharmacology & pharmacy | |
dc.title | Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro | |
dc.type | Article | |
dc.wos.quartile | Q3 | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Tıbbi Biyokimya Ana Bilim Dalı | |
local.contributor.department | Fen Edebiyat Fakültesi/Biyoloji Bölümü | |
local.indexed.at | WOS | |
local.indexed.at | Scopus |
Files
License bundle
1 - 1 of 1
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: